11
Jul 24
Theranexus – Implementation of a new equity line up to €2.5 Millions
Lyon, France, Jul 11, 2024 – Theranexus, a biopharmaceutical company innovating in the treatmentof rare neurological diseases, today publishes its cash position as of 30 June 2024, presents a progress report on Batten-1 and opens a new equity line. DOWNLOAD Theranexus press release Lyon, France – 11 juillet 2024, –…